[1]
M. de A. Carvalho Sousa, G. C. Matos de Oliveira, and L. J. de Oliveira Andrade, “Surfactant in SARS-CoV-2 - a therapeutic option based on underlying lung cell damage?”, cmbio, vol. 19, no. 4, pp. 602–605, Dec. 2020.